Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|October 25, 2017
Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infectionSwee Lin G Chen Yi Mei, Alexander J Thompson, Britt Christensen, et al.Clinical and Experimental Gastroenterology|July 28, 2015
Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohortDavina Tribbick, Michael Salzberg, Maria Ftanou, et al.Alimentary Pharmacology & Therapeutics|June 8, 2020
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL studyMark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.Alimentary Pharmacology & Therapeutics|July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switchRaphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.Journal of Crohn'S & Colitis|September 2, 2025
Faecal loss of vedolizumab is associated with UC severity, lower serum vedolizumab levels and rates of clinical response: Results from the FAVOUR studyMark A Samaan, Georgina Cunningham, Samuel Hsiang Lim, et al.Pageof 2